ArticleOncotarget2025

Analytical validation of a circulating tumor DNA assay using PhasED-Seq technology for detecting residual disease in B-cell malignancies.

Nina Klimova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.